首页/数据集/Supplementary Table S1 from Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy

Supplementary Table S1 from Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy

Figshare2024-05-15 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Facts_and_Hopes_on_Chimeric_Cytokine_Agents_for_Cancer_Immunotherapy/25826468 数据链接链接失效反馈

官方服务：

资源简介：

Clinical trials related to IL-2- and IL-15 based chimeric cytokines

应用场景：

创建时间：

2024-05-15

消化道微生物组

癌症免疫治疗

Despite their success, immune checkpoint blockers (ICB) benefit only a subset of patients and pose potential risk of serious immune-related adverse events, underscoring the critical need for new strat

NIAID Data Ecosystem110

Activation of a collaborative innate-adaptive immune response suppresses metastatic breast and ovarian cancer in mice. Activation of a collaborative innate-adaptive immune response suppresses metastatic breast and ovarian cancer in mice

癌症免疫治疗

转移性乳腺癌

Many cancers recruit monocytes/macrophages and polarize them into tumor-associated macrophages (TAMs). TAMs promote tumor growth and metastasis and inhibit cytotoxic T cells, preventing immune control

NIAID Data Ecosystem100

Across-cancer immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis

癌症免疫治疗

纳米疫苗研发

Across-cancer immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis

integrated proteome resources30

Code files for submission

癌症免疫治疗

组合疗法

Diverse combination therapies are being investigated to overcome the limitations of immune checkpoint inhibitors. However, determining the optimal combination therapy remains a challenge. Herein, we d

DataCite Commons2024-03-01 更新110

Tumor Infiltrating Lymphocytes (TIL) Recognize Unique Somatic Mutations and Mediate Objective Clinical Responses in Metastatic Breast Cancer

癌症免疫治疗

过继性细胞疗法

The purpose of this study is to investigate the immunogenicity of tumor mutations in patients with metastatic cancer. Harvest and analysis of progressing metastatic lesions are used for generation of

NIAID Data Ecosystem40

Supplementary Table S1 from Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy

资源简介：

相关数据集